Largest pharmaceutical companies in the United States by revenue

Everything the company sold in its latest fiscal year, before any cost is taken off.

Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at $94.2B, ahead of Eli Lilly ($65.2B) and Merck & Co ($65B). Figures as of 19 Nov 2026, 16:24 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
36
First
Johnson & Johnson$94.2B
Median
$1.4B
Combined market value
$3.73T
Countries
1
Not ranked
8no revenue on file

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Largest pharmaceutical companies in the United States by revenue
#CompanyRevenue ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Johnson & JohnsonJNJ · Health Care$94.2B$637.7B$264.92 2.85% down 34% up United States
2Eli LillyLLY · Health Care$65.2B$1.20T$1,349.94 2.37% down 33% up United States
3Merck & CoMRK · Health Care$65B$329.3B$133.59 3.04% down 45% up United States
4PfizerPFE · Health Care$62.6B$157.1B$27.57 1.75% down 15% up United States
5AbbVieABBV · Health Care$61.2B$496.3B$280.80 1.82% down 25% up United States
6Bristol-Myers SquibbBMY · Health Care$48.2B$119.2B$58.32 2.08% down 30% up United States
7Abbott LaboratoriesABT · Health Care$44.3B$181B$104.52 0.03% up 16% down United States
8Regeneron PharmaceuticalsREGN · Health Care$14.3B$96.4B$931.84 1.45% down 28% up United States
9ViatrisVTRS · Health Care$14.3B$22.8B$19.85 2.14% down 99% up United States
10Vertex PharmaceuticalsVRTX · Health Care$12B$132.9B$524.32 2.26% down 27% up United States
11ZoetisZTS · Health Care$9.5B$33.4B$82.12 4.03% down 26% down United States
12Elanco Animal HealthELAN · Health Care$4.7B$13.2B$26.51 0.73% down 26% up United States
13Alnylam PharmaceuticalsALNY · Health Care$3.7B$19.9B$148.86 0.36% down 66% down United States
14BioMarin PharmaceuticalBMRN · Health Care$3.2B$12.2B$62.83 2.28% up 17% up United States
15United TherapeuticsUTHR · Health Care$3.2B$24.1B$564.79 2.17% down 22% up United States
16Amneal PharmaceuticalsAMRX · Health Care$3B$7.5B$21.39 2.26% down 90% up United States
17Royalty PharmaRPRX · Health Care$2.4B$39B$67.75 1.35% down 79% up United States
18PTC TherapeuticsPTCT · Health Care$1.7B$5B$60.35 0.19% up 21% down United States
19Legend BiotechLEGN · Health Care$1B$3.1B$16.22 0.22% down 41% down United States
20Madrigal PharmaceuticalsMDGL · Health Care$958.4M$9.4B$403.83 1.44% up 27% down United States
21Ionis PharmaceuticalsIONS · Health Care$943.7M$4.5B$27.02 1.37% down 63% down United States
22Arrowhead PharmaceuticalsARWR · Health Care$829.4M$6.1B$43.50 0.90% up 13% up United States
23Corcept TherapeuticsCORT · Health Care$761.4M$7.2B$65.82 2.91% down 10% down United States
24Axsome TherapeuticsAXSM · Health Care$638.5M$7.1B$134.26 0.19% up 6% down United States
25TG TherapeuticsTGTX · Health Care$616.3M$10.1B$66.53 0.62% up 117% up United States
26InsmedINSM · Health Care$606.4M$31.4B$143.11 19.46% up 40% down United States
27Mirum PharmaceuticalsMIRM · Health Care$521.3M$6.2B$94.67 2.36% up 34% up United States
28BridgeBio PharmaBBIO · Health Care$502.1M$15.2B$78.15 0.18% up 21% up United States
29Travere TherapeuticsTVTX · Health Care$490.7M$4.8B$49.70 1.07% down 45% up United States
30Ligand PharmaceuticalsLGND · Health Care$268.1M$5.8B$291.42 2.44% down 50% up United States
31Rhythm PharmaceuticalsRYTM · Health Care$189.8M$8.1B$116.68 1.98% down 18% up United States
32CytokineticsCYTK · Health Care$88M$7.2B$51.38 0.12% up 19% down United States
33Protagonist TherapeuticsPTGX · Health Care$46M$8.3B$126.50 0.52% down 51% up United States
34Dianthus TherapeuticsDNTH · Health Care$2M$4.8B$85.51 1.82% up 108% up United States
35Spyre TherapeuticsSYRE · Health Care$0$9.4B$99.07 2.36% down 332% up United States
36Praxis Precision MedicinesPRAX · Health Care$0$8.9B$318.93 4.50% up 86% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. 8 companies have no revenue on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States rank first by revenue?

Johnson & Johnson ($94.2B), Eli Lilly ($65.2B) and Merck & Co ($65B) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 19 Nov 2026, 16:24 UTC.

How many pharmaceutical companies in the United States are in this ranking?

36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of $3.73T as of 19 Nov 2026, 16:24 UTC.

What does ranking by revenue measure?

Everything the company sold in its latest fiscal year, before any cost is taken off.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue

Underlying data: Yahoo Finance; SEC EDGAR.